Sachin G. Thakkar

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Andras Heczey, Xin Xu, Amy N. Courtney et al. · Nature Medicine · 2023 · 161 citations

Cell Therapy, Refractory Neuroblastoma, Medicine +7

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

David Steffin, Nisha Ghatwai, Antonino Montalbano et al. · Nature · 2024 · 150 citations · Full text

Cancer Immunosurveillance, Solid Cancers, Medicine +5

Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate

Abdulaziz M. Aldayel, Hannah L. O’Mary, Solange A. Valdes et al. · Journal of Controlled Release · 2018 · 122 citations

Inflammation, Nanomedicine, Rheumatology +12

Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies

Norihiro Watanabe, Feiyan Mo, Rong Zheng et al. · Molecular Therapy · 2022 · 69 citations · Full text

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Meenakshi Hegde, Shoba A. Navai, Christopher DeRenzo et al. · Nature Cancer · 2024 · 64 citations · Full text

Cell Therapy, Cancer Immunosurveillance, Medicine +7